ARA-290 Reconstitution, Storage and Handling for Laboratory Research

Reviewed for accuracy by the Gorilla Research Labs research team · 2026-07-04

RESEARCH ARA-290 Reconstitution, Storage and Handling for Laboratory Research ARA-290 is a synthetic peptide designed as a non-erythropoietic ligand of the innate repair receptor, currently utilized in controlled laboratory environments to probe tissue-protective pathways. Proper handling of this compound requires strict adherence to cold-chain logistics and sterile technique to maintain the integrity of the peptide’s molecular structure during experimental procedures. Compound identity: CAS 1208243-50-8 · C51H84N16O21 · 1257.3 g/mol (verified via PubChem)

The Molecular Profile of ARA-290

ARA-290, also known as cibinetide, is an 11-amino-acid peptide engineered to mimic the tissue-protective properties of erythropoietin without stimulating erythropoiesis ^[2]. In research settings, it is primarily studied for its ability to bind to the innate repair receptor, a heteromeric complex consisting of the erythropoietin receptor and the common beta-receptor ^[1]. Because this compound is a synthetic peptide, its stability is highly dependent on environmental variables such as pH, temperature, and exposure to light. The research literature has focused on its capacity to modulate inflammatory signaling and neuropathic pain pathways in specific clinical models ^[1], ^[2]. However, the molecular stability of the compound in varying solvent systems remains a subject of ongoing laboratory optimization. Researchers must distinguish between the peptide’s behavior in controlled, buffered aqueous environments versus its stability in lyophilized form, as these states present different challenges for experimental reproducibility.

Lyophilized Storage and Integrity

Lyophilization is a standard process used to increase the shelf-life of peptides by removing water under vacuum, effectively arresting chemical degradation pathways that require moisture. In a research laboratory, the integrity of the lyophilized powder is paramount. While storage at -20°C or -80°C is common practice for peptide preservation, the specific degradation kinetics of ARA-290 under these conditions have not been formally established in the literature ^[1], ^[2]. While the literature provides insights into the physiological effects of ARA-290 in human pilot studies—such as its investigation in sarcoidosis-associated small-fiber neuropathy ^[1]—it does not explicitly detail the degradation kinetics of the lyophilized powder under ambient light or fluctuating humidity. Consequently, the research community relies on standardized cold-chain management to ensure that the material remains consistent with the specifications provided in the Certificate of Analysis (COA) for each specific lot.

Solvent Selection and Reconstitution Dynamics

Reconstitution is the transition point where a stable, solid-state compound enters a dynamic, liquid-phase experimental environment. The choice of solvent is critical; researchers typically utilize sterile, bacteriostatic water or phosphate-buffered saline (PBS) to ensure physiological compatibility. The goal is to achieve complete dissolution without inducing mechanical stress or localized pH shifts that could lead to peptide misfolding. ARA-290 has been evaluated in clinical research for its potential to reduce neuropathic pain in patients with type 2 diabetes ^[2] and sarcoidosis-associated small-fiber neuropathy ^[1]. These studies underscore the importance of precision in preparation. However, the literature does not provide a universal "gold standard" for the exact duration of stability once the peptide is moved into a liquid solvent. Therefore, laboratory protocols must prioritize immediate use or strict, short-term refrigerated storage to avoid the potential for hydrolysis or microbial contamination.

Environmental Sensitivity and Experimental Controls

Peptides are inherently sensitive to shear stress and thermal fluctuations. In the laboratory, repeated freeze-thaw cycles are generally avoided, as the transition between solid and liquid phases can lead to the formation of ice crystals that may disrupt the peptide’s tertiary structure. Researchers often aliquot the reconstituted material into smaller, single-use volumes to mitigate the need for repeated handling. Exposure to light is another variable that requires control. Many peptides are susceptible to photo-degradation, which can alter their chemical activity. Using amber-colored vials or storing samples in dark, climate-controlled environments is a standard precaution in high-fidelity laboratory settings. These measures are not merely procedural preferences; they are essential for ensuring that the data generated in a study is a result of the compound’s activity rather than a byproduct of degraded material.

Lot Tracking and Quality Verification

In any rigorous research environment, the traceability of the compound is as important as its handling. Every vial, identified by its specific lot number, should be accompanied by a comprehensive COA that details purity, molecular weight verification, and residual solvent analysis. Researchers must maintain a log that tracks the receipt, storage conditions, and usage of each lot to ensure that experimental results can be correlated with the specific batch of material used. Verification of material purity—often conducted via High-Performance Liquid Chromatography (HPLC) or Mass Spectrometry (MS)—is the final safeguard in laboratory practice. By confirming that the peptide matches the expected molecular profile before it is introduced into an experimental model, researchers minimize the risk of confounding variables. This methodical approach to material management is the bedrock of reproducible science, allowing for the consistent evaluation of ARA-290 across diverse research applications.

Frequently asked questions

What is the recommended storage temperature for ARA-290? For long-term storage, the lyophilized powder is typically kept at -20°C or -80°C to maintain structural integrity. The literature on ARA-290 focuses on its therapeutic potential in human trials ^[1], ^[2], but does not define exact degradation rates at specific temperatures; therefore, maintaining a consistent, low-temperature cold chain is the standard laboratory precaution. Can ARA-290 be frozen after it has been reconstituted? Repeated freeze-thaw cycles are generally discouraged in peptide research because they can cause structural degradation and loss of activity. Researchers typically aliquot the reconstituted solution into single-use volumes to avoid the need to thaw the same sample multiple times. How do researchers verify the purity of their research compounds? Researchers verify material quality by reviewing the Certificate of Analysis (COA) provided with each lot. This document typically includes data from HPLC and MS, which confirm the peptide's purity and molecular mass, ensuring that the material is suitable for high-precision experimental work. Why is lot tracking important in laboratory research? Lot tracking allows researchers to maintain a clear chain of custody and ensures that if experimental results vary, they can be cross-referenced with the specific batch of material used. This practice is essential for identifying potential variability in experimental outcomes. What is the difference between the vial quantity and the molecular weight? The "80MG" or similar figures often found on labels refer to the total mass of the lyophilized material in the vial, not the molecular weight of the peptide itself. Researchers must refer to the provided COA for the precise molecular weight and purity specifications of the compound. Research use only. The compounds discussed are supplied for laboratory research and are not for human or veterinary use. Nothing on this page is medical advice, a dosing guide, or a claim about any product sold here; it summarises published research and cites its sources.